• News
  • Video
  • Image
  • Music
  • List
  • Poll
  • Trivia Quiz
  • Link
The PharmaCanada

Your Compass in Canadian Pharma

  • Home
  • News
    • Drug Approvals
    • Regulatory Affairs
    • Clinical Pipeline
    • Biotech & Genomics
    • Deals & Finance
    • MedTech & Digital Health
    • Policy & Access
    • Research & Academia
    • Industry & Business
    • Events
  • Regulatory
  • Pipeline
  • Deals & Finance
  • Policy
  • Subscribe
Profile
More
News Video Image Music
  • Home
  • News
  • Regulatory
  • Pipeline
  • Deals & Finance
  • Policy
  • Subscribe
    • Categories
    • Categories v2
    • Explore
    • NSFW
    • Reactions
    • Trend
    • Users
    • Users v2
    Login
    • Categories
    • Categories v2
    • Explore
    • NSFW
    • Reactions
    • Trend
    • Users
    • Users v2
    • News
      Regulatory Affairs

      Health Canada approves Empaveli (pegcetacoplan) for C3G/IC-MPGN

      Health Canada has approved Empaveli (pegcetacoplan) as the first treatment…

      0 10 0
      April 16, 2026
    • Drug Approvals

      Health Canada approves Cysklar (cysteamine ophthalmic solution) for cystinosis-related corneal crystals

      Takeaways: Cysklar gives Canada’s small cystinosis community a dedicated, easy‑to‑use…

      0 3 0
      April 15, 2026
    • Drug Approvals

      Health Canada grants NOC to Saphnelo (anifrolumab) SC autoinjector for SLE

      Takeaways: AstraZeneca deepens its Saphnelo franchise in Canada by adding…

      0 2 0
      April 13, 2026
    • Drug Approvals

      Health Canada approves Denoza, a biosimilar to Prolia (denosumab)

      Takeaways: Apotex’s Denoza biosimilar gives Canada a home‑grown denosumab option,…

      0 2 0
      April 7, 2026
    • Clinical Pipeline

      Health Canada clears CTA for AFTX-201 in BAG3 DCM, to be evaluated in Phase 1/2 UPBEAT trial

      Takeaways: Health Canada’s CTA clearance positions Affinia among the first…

      0 2 0
      April 6, 2026

    Recent Posts

    • Health Canada approves Empaveli (pegcetacoplan) for C3G/IC-MPGN
    • Health Canada approves Cysklar (cysteamine ophthalmic solution) for cystinosis-related corneal crystals
    • Health Canada grants NOC to Saphnelo (anifrolumab) SC autoinjector for SLE
    • Health Canada approves Denoza, a biosimilar to Prolia (denosumab)
    • Health Canada clears CTA for AFTX-201 in BAG3 DCM, to be evaluated in Phase 1/2 UPBEAT trial

    Recent Comments

    No comments to show.

    Log In

    Forgot password?

    Add Link